IMPORTANT ANNOUNCEMENT: Deadline for BioVie Class Action Lawsuit; Contact Johnson Fistel to Secure Your Rights Now
04 mars 2024 05h54 HE
|
Johnson Fistel, LLP
Deadline for BioVie Class Action Lawsuit
Arcutis Announces Pricing of $150 Million Public Offering
28 févr. 2024 23h30 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced the pricing of its underwritten public offering of common stock.
Wetouch Technology Inc. Announces Closing of $10.8 Million Public Offering of Common Stock
23 févr. 2024 16h00 HE
|
Wetouch Technology Inc.
Meishan, Sichuan, China, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Wetouch Technology Inc. (Nasdaq: WETH ) (“Wetouch” or the “Company”), a Nevada company, through its wholly-owned subsidiary, engaged in the...
Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering
21 févr. 2024 23h00 HE
|
Draganfly Inc
Saskatoon, SK., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the...
Ohmyhome Announces Pricing of Upsized $4.8 Million Public Offering of Ordinary Shares
13 févr. 2024 22h35 HE
|
Ohmyhome Ltd.
Singapore, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell,...
Evaxion Announces Closing of $15 Million Public Offering
06 févr. 2024 08h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
SINTX Technologies Announces Closing of $4.0 Million Public Offering
02 févr. 2024 14h33 HE
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, Feb. 02, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the...
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
01 févr. 2024 16h22 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Evaxion Biotech Announces Pricing of $15 Million Public Offering
01 févr. 2024 09h20 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
31 janv. 2024 11h15 HE
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals (Nasdaq: SXTP) closes $2.4 million public offering.